Erica B Wilson (Erica Watson, Erica Wilson, E B Wilson)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Transforming Growth Factor

Multiple Myeloma

Endoplasmic Reticulum Stress

Top Venues

Clinical and experimental immunology

Science translational medicine

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Rebecca J Brownlie, Ruth Kennedy, Erica B Wilson, Maja Milanovic, Claire F Taylor, Dapeng Wang, John Davies, Heather Elizabeth Owston, Emma J Adams, Sophie Stephenson, Rebecca Caeser, Benjamin E Gewurz, Peter V Giannoudis, Claudio Scuoppo, Dennis McGonagle, Daniel James Hodson, Reuben M Tooze, Gina M Doody, Curly T C M Morris, David Robert Westhead, Ulf Klein
Cytokine receptor IL27RA is an NF-kB-responsive gene involved in CD38 upregulation in multiple myeloma. Blood advances (2023)
Erica B Wilson, Ulf Klein
An MYC-Driven Vicious Circuit Is a Targetable Achilles' Heel in Lymphoma. Blood cancer discovery (2023)
Tereza Andreou, Jennifer Williams, Rebecca J Brownlie, Robert J Salmond, Erica B Wilson, Gary C Shaw, Alan A Melcher, Heiko Wurdak, Susan C Short, Mihaela Lorger
Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model. Journal for immunotherapy of cancer 9 (3) (2021)
H J Close, Lucy F Stead, J Nsengimana, K A Reilly, Alastair P Droop, Heiko Wurdak, Ryan Koshy Mathew, R Corns, J Newton-Bishop, Alan A Melcher, Susan C Short, Graham P Cook, Erica B Wilson
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma. Clinical and experimental immunology 200 (1) (2019)
Adel Samson, Karen J Scott, David Taggart, Emma J West, Erica B Wilson, Gerard J Nuovo, Simon Thomson, Robert Corns, Ryan Koshy Mathew, Martin J Fuller, Timothy J Kottke, Jill M Thompson, Elizabeth J Ilett, Julia V Cockle, Philip van Hille, Gnanamurthy Sivakumar, Euan S Polson, Samantha J Turnbull, Elizabeth S Appleton, Gemma Migneco, Ailsa S Rose, Matthew C Coffey, Deborah A Beirne, Fiona J Collinson, Christy Ralph, Alan Anthony, Christopher J Twelves, Andrew J Furness, Sergio A Quezada, Heiko Wurdak, Fiona Errington-Mais, Hardev Pandha, Kevin J Harrington, Peter John Selby, Richard G Vile, Stephen D Griffin, Lucy F Stead, Susan C Short, Alan A Melcher
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Science translational medicine 10 (422) (2019)